Physiological Dose of EGCG Attenuates the Health Defects of High Dose by Regulating MEMO-1 in Caenorhabditis elegans

Figure 5

EGCG mitigates and recovers health side effects by restoring mitochondrial function. (a) Relative ATP level treatment with high dose of EGCG during the larval development compared to control. , , and , by two-way ANOVA. (b) Relative ATP level treatment with high dose of EGCG at day 0 and day 2 and maintained it at day 4 of adulthood. Compared to control, , , and , by two-way ANOVA. (c) Estimation body length per worm during the larva development; three replicate experiments; worms. , , and , by two-way ANOVA.

(a)

(b)

(c)